TBC1D9
From Wikipedia, the free encyclopedia
| TBC1 domain family, member 9 (with GRAM domain) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||
| Symbols | TBC1D9; MDR1 | ||||||||||
| External IDs | HomoloGene: 57079 GeneCards: TBC1D9 Gene | ||||||||||
| |||||||||||
| RNA expression pattern | |||||||||||
 | |||||||||||
 | |||||||||||
| More reference expression data | |||||||||||
| Orthologs | |||||||||||
| Species | Human | Mouse | |||||||||
| Entrez | 23158 | 71310 | |||||||||
| Ensembl | ENSG00000109436 | ENSMUSG00000031709 | |||||||||
| UniProt | Q6ZT07 | Q3UYK3 | |||||||||
| RefSeq (mRNA) | NM_015130 | NM_001111304 | |||||||||
| RefSeq (protein) | NP_055945 | NP_001104774 | |||||||||
| Location (UCSC) | Chr 4: 141.54 – 141.68 Mb | Chr 8: 83.17 – 83.27 Mb | |||||||||
| PubMed search | |||||||||||
TBC1 domain family member 9 is a protein that in humans is encoded by the TBC1D9 gene.[1][2]
References
- ↑ Islam TC, Asplund AC, Lindvall JM, Nygren L, Liden J, Kimby E, Christensson B, Smith CI, Sander B (Sep 2003). "High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma". Leukemia 17 (9): 1880–1890. doi:10.1038/sj.leu.2403057. PMID 12970790.
- ↑ "Entrez Gene: TBC1D9 TBC1 domain family, member 9 (with GRAM domain)".
Further reading
- Andersson B, Wentland MA, Ricafrente JY et al. (1996). "A "double adaptor" method for improved shotgun library construction". Anal. Biochem. 236 (1): 107–113. doi:10.1006/abio.1996.0138. PMID 8619474.
- Yu W, Andersson B, Worley KC et al. (1997). "Large-scale concatenation cDNA sequencing". Genome Res. 7 (4): 353–8. doi:10.1101/gr.7.4.353. PMC 139146. PMID 9110174.
- Nagase T, Ishikawa K, Suyama M et al. (1999). "Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro". DNA Res. 5 (6): 355–364. doi:10.1093/dnares/5.6.355. PMID 10048485.
- Dias Neto E, Correa RG, Verjovski-Almeida S et al. (2000). "Shotgun sequencing of the human transcriptome with ORF expressed sequence tags". Proc. Natl. Acad. Sci. U.S.A. 97 (7): 3491–3496. doi:10.1073/pnas.97.7.3491. PMC 16267. PMID 10737800.
- Strausberg RL, Feingold EA, Grouse LH et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–16903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Brandenberger R, Wei H, Zhang S et al. (2005). "Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation". Nat. Biotechnol. 22 (6): 707–716. doi:10.1038/nbt971. PMID 15146197.
- Beausoleil SA, Jedrychowski M, Schwartz D et al. (2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins". Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–12135. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935.
- Rodríguez Nóvoa S, Barreiro P, Rendón A et al. (2006). "Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1". Clin. Infect. Dis. 42 (2): 291–295. doi:10.1086/499056. PMID 16355344.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.